<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04985500</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY-20-01473</org_study_id>
    <nct_id>NCT04985500</nct_id>
  </id_info>
  <brief_title>ESP/PIF for Sternotomy</brief_title>
  <official_title>Erector Spinae Plane Block vs. Pecto-intercostal Fascial Plane Block vs. Control for Sternotomy: A Prospective Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Icahn School of Medicine at Mount Sinai</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Icahn School of Medicine at Mount Sinai</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized study. The purpose of this study is to evaluate the effect of&#xD;
      post-surgical pain control of two types of peripheral nerve blocks, specifically erector&#xD;
      spinal plane (ESP) block and pecto-intercostal fascial (PIF) plane block.&#xD;
&#xD;
      90 subjects, from 18-85 years of age, undergoing cardiac surgery with median sternal incision&#xD;
      will be enrolled at Mount Sinai Morningside Hospital Center. Study participation will last&#xD;
      from the time of pre-operative evaluation to 72 hours after surgery. Subjects will be&#xD;
      randomly assigned to receive 1 of the 3 different regimens at the beginning of surgery.&#xD;
      Opioid consumption and pain scores after surgery will be evaluated. Though unlikely, risks&#xD;
      include systemic absorption of local anesthetic, which can result in both central nervous&#xD;
      system and cardiac toxicity.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2021</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <intervention_model_description>Patients will be assigned randomly using a computer-generated table of numbers to one of the three groups: 1) ESP group, 2) PIF group, or 3) no block group.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
    <masking_description>The anesthesiologist assessing the patient will be blinded</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Opioid Consumption during first 24 hours post-op</measure>
    <time_frame>Post-operative 24 hours</time_frame>
    <description>The amount of opioid consumption (in mg IV morphine equivalents) during the first 24 hours post-op in patients undergoing cardiac surgeries with median sternotomy.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Opioid Consumption during first 48 hours post-op</measure>
    <time_frame>Post-operative 48 hours</time_frame>
    <description>The amount of opioid consumption (in mg IV morphine equivalents) during the first 48 hours post-op in patients undergoing cardiac surgeries with median sternotomy.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Opioid Consumption during first 72 hours post-op</measure>
    <time_frame>Post-operative 72 hours</time_frame>
    <description>The amount of opioid consumption (in mg IV morphine equivalents) during the first 72 hours post-op in patients undergoing cardiac surgeries with median sternotomy.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Score (VAS) Pain Score post-op 24 hours</measure>
    <time_frame>Post-operative 24 hours</time_frame>
    <description>VAS Pain Score from 0-10, with higher score indicating more pain. The average VAS pain scores during the first 24 hours post-op in patients undergoing cardiac surgeries with median sternotomy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Score (VAS) Pain Score post-op 48 hours</measure>
    <time_frame>Post-operative 48 hours</time_frame>
    <description>VAS Pain Score from 0-10, with higher score indicating more pain. The average VAS pain scores during the first 48 hours post-op in patients undergoing cardiac surgeries with median sternotomy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Score (VAS) Pain Score post-op 72 hours</measure>
    <time_frame>Post-operative 72 hours</time_frame>
    <description>VAS Pain Score from 0-10, with higher score indicating more pain. The average VAS pain scores during the first 72 hours post-op in patients undergoing cardiac surgeries with median sternotomy.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Cardiac Surgery</condition>
  <condition>Sternotomy</condition>
  <arm_group>
    <arm_group_label>ESP group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient will receive ESP block with ultrasound guidance the transverse process of the vertebra at T7 is visualized and 20 mL of 0.25% bupivacaine will be injected between the transverse process and the erector spinae muscle on each side using a 21-gauge block needle.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PIF group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient will receive PIF block after intubation with ultrasound placed 1-2 cm lateral to the sternal border and the pectoralis major and external intercostal muscles are visualized at the level of ribs 3-4 where 10 mL of 0.25% bupivacaine will be injected on each side using a 21-gauge block needle.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Block group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patient will not receive block.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ESP block</intervention_name>
    <description>peripheral nerve block</description>
    <arm_group_label>ESP group</arm_group_label>
    <other_name>erector spinal plane block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PIF block</intervention_name>
    <description>peripheral nerve block</description>
    <arm_group_label>PIF group</arm_group_label>
    <other_name>pecto-intercostal fascial plane block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ultrasound</intervention_name>
    <description>Ultrasound guidance</description>
    <arm_group_label>ESP group</arm_group_label>
    <arm_group_label>PIF group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacain</intervention_name>
    <description>10-20 mL of 0.25% bupivacaine</description>
    <arm_group_label>ESP group</arm_group_label>
    <arm_group_label>PIF group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults 18-85 years old&#xD;
&#xD;
          -  Scheduled to undergo cardiac procedures involving sternotomy&#xD;
&#xD;
          -  All genders&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  ASA class V&#xD;
&#xD;
          -  Urgent or emergent surgery&#xD;
&#xD;
          -  Contraindications to administration of local anesthesia (e.g. local anesthetic&#xD;
             allergy)&#xD;
&#xD;
          -  History of substance abuse or chronic opioid use&#xD;
&#xD;
          -  Patient refusal or inability to consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ali Shariat, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mount Sinai West and Morningside Hospitals</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Himani Bhatt, D.O.</last_name>
    <role>Study Director</role>
    <affiliation>Mount Sinai West and Morningside Hospitals</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shenghao Fang, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Mount Sinai West and Morningside Hospitals</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shenghao Fang, M.D.</last_name>
    <phone>434-326-8499</phone>
    <email>shenghao.fang@mountsinai.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ali Shariat, M.D.</last_name>
    <phone>914-409-5023</phone>
    <email>alinima.shariat@mountsinai.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mount Sinai Morningside Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10025</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Shenghao Fang, M.D.</last_name>
      <phone>434-326-8499</phone>
      <email>shenghao.fang@mountsinai.org</email>
    </contact>
    <contact_backup>
      <last_name>Ali Shariat, M.D.</last_name>
      <phone>914-409-5023</phone>
      <email>alinima.shariat@mountsinai.org</email>
    </contact_backup>
    <investigator>
      <last_name>Ali Shariat, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 6, 2021</study_first_submitted>
  <study_first_submitted_qc>July 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 2, 2021</study_first_posted>
  <last_update_submitted>July 22, 2021</last_update_submitted>
  <last_update_submitted_qc>July 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Icahn School of Medicine at Mount Sinai</investigator_affiliation>
    <investigator_full_name>Ali Nima Shariat</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>ESP Block</keyword>
  <keyword>PIF Block</keyword>
  <keyword>Cardiac Surgery</keyword>
  <keyword>Sternotomy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

